Physician Preferences on Biomarker Testing in Newly-Diagnosed metastatic NSCLC Patients Who had Insufficient Tumor Tissue
07:30am - 03:45pm EDT - April 1, 2023
07:30am - 03:45pm EDT - April 1, 2023
Author(s):
- Anne Shah, PhD, AstraZeneca Pharmaceuticals, LP
Tags: Outcomes and Health Services Research
| Display Label | Action |
|---|---|
| AC23P93 - Physician Preferences on Biomarker Testing in Newly-Diagnosed metastatic NSCLC Patients Who had Insufficient Tumor Tissue | Download MP3 |
| 093-General Poster Session | Download Resource |
